[go: up one dir, main page]

DD134106A5 - Verfahren zur herstellung von 17 beta-hydroxy-4-androsten-3-on-derivaten - Google Patents

Verfahren zur herstellung von 17 beta-hydroxy-4-androsten-3-on-derivaten

Info

Publication number
DD134106A5
DD134106A5 DD76204013A DD20401376A DD134106A5 DD 134106 A5 DD134106 A5 DD 134106A5 DD 76204013 A DD76204013 A DD 76204013A DD 20401376 A DD20401376 A DD 20401376A DD 134106 A5 DD134106 A5 DD 134106A5
Authority
DD
German Democratic Republic
Prior art keywords
androstene
derivatives
preparing
beta hydroxy
beta
Prior art date
Application number
DD76204013A
Other languages
English (en)
Inventor
Alfred Weber
Mario Kennecke
Rudolf Mueller
Ulrich Eder
Rudolf Wiechert
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DD134106A5 publication Critical patent/DD134106A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0011Androstane derivatives substituted in position 17 by a keto group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0018Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa
    • C07J1/0022Androstane derivatives substituted in position 17 beta, not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0003Androstane derivatives
    • C07J1/0033Androstane derivatives substituted in position 17 alfa and 17 beta
    • C07J1/004Androstane derivatives substituted in position 17 alfa and 17 beta the substituent in position 17 alfa being an unsaturated hydrocarbon group
    • C07J1/0048Alkynyl derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids
    • C12P33/005Degradation of the lateral chains at position 17
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/832Bacillus
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/84Brevibacterium
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/863Mycobacterium
    • Y10S435/866Mycobacterium smegmatis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/872Nocardia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/822Microorganisms using bacteria or actinomycetales
    • Y10S435/886Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DD76204013A 1975-12-19 1976-12-17 Verfahren zur herstellung von 17 beta-hydroxy-4-androsten-3-on-derivaten DD134106A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2558088A DE2558088C2 (de) 1975-12-19 1975-12-19 Verfahren zur Herstellung von 4-Androsten-3,17-dion-Derivaten

Publications (1)

Publication Number Publication Date
DD134106A5 true DD134106A5 (de) 1979-02-07

Family

ID=5965329

Family Applications (2)

Application Number Title Priority Date Filing Date
DD7600196440A DD129334A5 (de) 1975-12-19 1976-12-17 Verfahren zur herstellung von 4-androsten-3,17-dion-derivaten
DD76204013A DD134106A5 (de) 1975-12-19 1976-12-17 Verfahren zur herstellung von 17 beta-hydroxy-4-androsten-3-on-derivaten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DD7600196440A DD129334A5 (de) 1975-12-19 1976-12-17 Verfahren zur herstellung von 4-androsten-3,17-dion-derivaten

Country Status (14)

Country Link
US (1) US4100027A (de)
JP (1) JPS5294493A (de)
AT (1) AT367092B (de)
BE (1) BE849557A (de)
CH (1) CH622532A5 (de)
CS (1) CS187348B2 (de)
DD (2) DD129334A5 (de)
DE (1) DE2558088C2 (de)
DK (1) DK139267C (de)
FR (1) FR2335522A1 (de)
GB (1) GB1571913A (de)
HU (1) HU183022B (de)
IE (1) IE44515B1 (de)
NL (1) NL7614024A (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4223092A (en) * 1977-10-21 1980-09-16 The Upjohn Company Process for preparing 9α-OH BN acid methyl ester
US4383947A (en) * 1981-07-24 1983-05-17 The Upjohn Company Introduction of a fluorine atom
GB2104526B (en) * 1981-07-24 1985-06-05 Upjohn Co 6-fluoro-9-hydroxyandrost-4-ene-3,17-diones and microbial preparation thereof
US5227375A (en) * 1990-02-08 1993-07-13 Endorecherche, Inc. Aromatase inhibitors
WO1999007381A1 (en) * 1997-08-11 1999-02-18 Weider Nutrition International, Inc. Compositions and treatments to reduce side effects of administration of androgenic testosterone precursors
US6071714A (en) * 1998-03-26 2000-06-06 Forbes Medi-Tech, Inc. Process for the microbial conversion of phytosterols to androstenedione and androstadienedione
DE19827523A1 (de) * 1998-06-22 1999-12-23 Jenapharm Gmbh Ungesättigte 14,15-Cyclopropano-Androstane, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate
KR100432054B1 (ko) * 2001-05-11 2004-05-17 (주)유진사이언스 스테롤로부터 4-안드로스텐-3,17-디온/안드로스타-1,4-디엔-3,17-디온으로의 뛰어난 전환능을 가지는 미생물 및 이의 제조방법
BRPI0306736B8 (pt) * 2002-01-21 2021-05-25 Akzo Nobel Nv processo para a preparação de 7alfa-metilesteróides, e, composto
US20040010138A1 (en) * 2002-03-21 2004-01-15 Schering Ag Process for the production of 7alpha-methyl steroids
DE10213371C1 (de) * 2002-03-21 2003-12-24 Schering Ag Verfahren zur Herstellung von 7alpha-Methylsteroiden
AR061892A1 (es) * 2007-07-11 2008-10-01 Consejo Nac Invest Cient Tec Un compuesto que presenta actividad antiinflamatoria y actividad antiviral, composiciones farmaceuticas que lo comprenden, un procedimiento para su obtencion y uso del mismo en el tratamiento de la queratoconjuntivitis epidemica y de la queratitis estromal herpetica

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1092145A (en) * 1964-06-02 1967-11-22 Noda Inst For Scientific Res Microbiological conversion of steroids
NL6705450A (de) * 1965-10-22 1968-10-21
US3684657A (en) * 1970-05-11 1972-08-15 Searle & Co Selective microbiological degradation of steroidal 17-alkyls
US3759791A (en) * 1970-12-10 1973-09-18 Searle & Co Selective microbiological preparation of androst-4-ene-3,17-dione

Also Published As

Publication number Publication date
HU183022B (en) 1984-04-28
US4100027A (en) 1978-07-11
IE44515L (en) 1977-06-19
JPS5294493A (en) 1977-08-09
DK139267B (da) 1979-01-22
DE2558088A1 (de) 1977-07-07
CH622532A5 (de) 1981-04-15
GB1571913A (en) 1980-07-23
JPS615715B2 (de) 1986-02-20
NL7614024A (nl) 1977-06-21
FR2335522B1 (de) 1980-07-04
AT367092B (de) 1982-05-25
BE849557A (fr) 1977-06-17
DE2558088C2 (de) 1985-05-30
DK566176A (da) 1977-06-20
DK139267C (da) 1979-06-25
FR2335522A1 (fr) 1977-07-15
DD129334A5 (de) 1978-01-11
IE44515B1 (en) 1981-12-30
ATA935676A (de) 1981-10-15
CS187348B2 (en) 1979-01-31

Similar Documents

Publication Publication Date Title
DD134526A5 (de) Verfahren zur herstellung von alkyloxinderivaten der 7-aminothiazolylazetamidozephalosporansaeure
DD128812A5 (de) Verfahren zur herstellung von chinazolonderivaten
DD129781A5 (de) Verfahren zur herstellung von glucoseaminderivaten
DD127900A5 (de) Verfahren zur herstellung von mercaptoazetidin-derivaten
DD134530A5 (de) Verfahren zur herstellung von n-thiolcarbonylderivaten von n-phosphonomethylglycin
DD128782A5 (de) Verfahren zur herstellung von n-alkyldiphenylaminen
AT351187B (de) Verfahren zur herstellung von 7-dehydrochol- esterinderivaten
DD134106A5 (de) Verfahren zur herstellung von 17 beta-hydroxy-4-androsten-3-on-derivaten
AT344147B (de) Verfahren zur herstellung von acylcyaniden
DD130576A5 (de) Verfahren zur herstellung von derivaten von 5-hydroxy-chininzarinchinon
DD132429A5 (de) Verfahren zur herstellung von derivaten von phenoxyalkansaeuren
ATA314576A (de) Verfahren zur herstellung von 4-nideralkyl-5- cyano-oxazolen
AT349032B (de) Verfahren zur herstellung von 4-alkyl-thiosemicarbaziden
DD132435A5 (de) Verfahren zur herstellung von indolochinolizinen
DD129790A5 (de) Verfahren zur herstellung von phenylpiperazinderivaten
DD131561A5 (de) Verfahren zur herstellung von 5-androsten-derivaten
DD122961A5 (de) Verfahren zur herstellung von diphenylaether-derivaten
DD135497A5 (de) Verfahren zur herstellung von 17 beta hydroxy-4-androsten-3-onen
ATA55178A (de) Verfahren zur herstellung von 1alpha-hydroxy- -cholesterin-derivaten
DD134107A5 (de) Verfahren zur herstellung von 17 beta-hydroxy-4-androsten-3-on-derivaten
DD129785A5 (de) Verfahren zur herstellung von indazolderivaten
DD125347A6 (de) Verfahren zur herstellung von oxazolderivaten
DD134105A5 (de) Verfahren zur herstellung von 17 beta-hydroxy-androstan-3-on-derivaten
DD135485A5 (de) Verfahren zur herstellung von nitroalkanolderivaten
DD125071A5 (de) Verfahren zur herstellung von farbstoffen